10,501 results match your criteria: "Kansai Medical University; 2-5-1 Shin-machi[Affiliation]"
Foods
September 2024
Department of Medical Chemistry, Kansai Medical University, 2-5-1 Shin-machi, Hirakata, Osaka 573-1010, Japan.
Besides all sharing an extraordinary high (i.e., up to ~450 times) sweetening power as compared to sucrose and while presenting strong similarities in their molecular structures, molecules belonging to the family of diterpene glycosides (i.
View Article and Find Full Text PDFCancers (Basel)
September 2024
BNCT Joint Clinical Institute, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki 569-8686, Japan.
The authors wish to make the following corrections to this paper [...
View Article and Find Full Text PDFCancers (Basel)
September 2024
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
Background: The short-term outcomes of chemoradiotherapy (CRT) with S-1 (a combination of tegafur, gimeracil, and oteracil) following limited surgery for patients with T1 or T2 lower rectal cancer have shown encouraging results.
Objectives: This study was designed to delve deeper into the long-term outcomes of CRT with S-1 after limited surgery, with the goal of evaluating both the long-term efficacy and potential risks associated with this treatment approach in patients diagnosed with T1 or T2 lower rectal cancer.
Methods: This was conducted as a multicenter, single-arm, prospective phase II trial.
J Clin Med
October 2024
Department of Gastroenterology, Toyonaka Municipal Hospital, Toyonaka 560-8565, Japan.
Although several reports have compared the outcomes of self-expandable metallic stent (SEMSs) and transanal decompression tube (TDT) placement for malignant colorectal obstruction (MCO), few studies have compared the radiation exposure (RE) associated with these two procedures. Consequently, we aimed to compare the RE of SEMS and TDT placements for MCO using propensity score matching (PSM) in a multi-center, prospective observational study. This study investigated the clinical data of 236 patients who underwent SEMS or TDT placement.
View Article and Find Full Text PDFNat Commun
October 2024
Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
Centrioles define centrosome structure and function. Deregulation of centriole numbers can cause developmental defects and cancer. The p53 tumor suppressor limits the growth of cells lacking or harboring additional centrosomes and can be engaged by the "mitotic surveillance" or the "PIDDosome pathway", respectively.
View Article and Find Full Text PDFJAMA Netw Open
October 2024
Department of Neurology, Medical University of Graz, Graz, Austria.
Int J Clin Oncol
December 2024
Division of Molecular and Diagnostic Pathology, Graduate School of Medical and Dental Sciences, Niigata University, 757 Ichibancho, Asahimachi-dori, Chuo Ward, Niigata, Japan.
Background: Lateral node metastasis confers a poor prognosis in rectal cancer. Several multidisciplinary treatments have been proposed with favorable outcomes. However, appropriate neoadjuvant/adjuvant treatments or follow-up plans based on information about the probable recurrence site have not been specified.
View Article and Find Full Text PDFAnn Surg Oncol
January 2025
Department of Urology and Andrology, Kansai Medical University, Osaka, Japan.
Environ Health Prev Med
October 2024
Department of Environmental Medicine, Saga University.
Amino Acids
October 2024
Department of Nephrology, Osaka University Graduate School of Medicine, Osaka, Japan.
D-Alanine, a rare enantiomer of alanine, can potentially alleviate the worsening of viral infections and maintain circadian rhythm. This study aimed to analyze the kinetics of D-Alanine upon oral intake. Five healthy volunteers were administered D-Alanine as a single oral dose at 11,236 or 33,708 µmoL (1-3 g).
View Article and Find Full Text PDFSpine Surg Relat Res
September 2024
Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
Int Cancer Conf J
October 2024
Department of Dermatology, Kansai Medical University Hospital, 2-5-1 Shinmachi, Hirakata City, Osaka Japan.
Immune checkpoint inhibitors (ICIs) can cause immune-related adverse events (irAEs) in various organs. Herein, we present a rare case involving a patient with immunotherapy-related gastritis who developed refractory vomiting and anorexia after treatment with nivolumab for cutaneous malignant melanoma. The patient was treated with oral corticosteroids, but the efficacy was limited.
View Article and Find Full Text PDFClin Interv Aging
October 2024
Department of Healthcare Innovation, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Purpose: As the number of older adults in society increases, their social roles and networks, as well as their physical function, decrease. This study aimed to clarify the association between social networks and physical function among people aged ≥ 60 years in rural Thailand.
Patients And Methods: This cross-sectional study was conducted in the Photharam District, Ratchaburi Province, Thailand.
Int J Colorectal Dis
October 2024
Department of Gastroenterological Surgery, Yokohama City University Graduate school of Medicine, Yokohama, Japan.
Purpose: Diverting ileostomy is related to postoperative high-output stoma (HOS) leading to kidney injury. The purpose of our study was to clarify the risk factors for ileostomy-associated kidney injury, which is kidney injury starting after the first operation to ileostomy closure after colorectal tumor surgery with diverting ileostomy.
Methods: Between January 2013 and December 2020, 442 patients who underwent colorectal tumor surgery (cancer, neuroendocrine tumor, and leiomyosarcoma) following diverting ileostomy formation were included.
BMC Pulm Med
October 2024
Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Oncology
October 2024
Department of Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute Hospital, Milan, Italy.
Introduction: The most frequently used first-line treatment in patients with advanced hepatocellular carcinoma (HCC) is atezolizumab plus bevacizumab. Upon progression after this treatment, the standard of care in many countries is sorafenib, due to the lack of reimbursement for other drugs. Several randomized trials are currently underway to clarify the best second-line therapy in patients with HCC.
View Article and Find Full Text PDFJ Thorac Oncol
October 2024
JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Pain Med
January 2025
Department of Molecular-Targeting Prevention, Kyoto Prefectural University of Medicine, Kyoto, 602-8566, Japan.
Objective: The aim of this study was to evaluate the efficacy and safety of a single trigger point injection (TPI) of a local anesthetic for the treatment of myofascial pain syndrome (MPS) in patients with incurable cancer.
Methods: This multicenter, exploratory, open-label, randomized comparative trial was conducted in five specialized palliative care departments. Hospitalized patients with incurable cancer who had been experiencing pain related to MPS were randomized to receive either a TPI of 1% lidocaine plus conventional care (TPI group) or conventional care alone (control group).
Lung Cancer
November 2024
Department of Genome Biology, Kindai University, Faculty of Medicine, Japan.
Breast Cancer
January 2025
Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
Int J Clin Oncol
December 2024
Department of Urology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.
Eur Radiol
October 2024
Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Cancer Sci
December 2024
Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Bunkyo-ku, Tokyo, Japan.
J Pharm Health Care Sci
October 2024
Department of Pharmacy, Kansai Medical University Hospital, Hirakata, Japan.
Background: Morphine is effective in palliative care for patients with end-stage heart failure; however, its use is avoided in patients with impaired renal function because it tends to induce adverse effects. Although oxycodone has been reported to be a useful alternative, the evidence is insufficient. Therefore, we investigated the safety and efficacy of oxycodone in eight patients with end-stage heart failure complicated by chronic kidney disease.
View Article and Find Full Text PDFArch Phys Med Rehabil
October 2024
Department of Physical Therapy, Faculty of Rehabilitation, Kobe Gakuin University, Kobe, Japan.